Collagenase clostridium histolyticum
Qwo, Xiaflex, Xiapex (collagenase clostridium histolyticum) is an enzyme pharmaceutical. Collagenase clostridium histolyticum was first approved as Xiaflex on 2010-02-02. It is used to treat burns, dupuytren contracture, penile induration, and skin ulcer in the USA. It has been approved in Europe to treat dupuytren contracture.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
Qwo, Xiaflex
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| collagenase santyl | Biologic Licensing Application | 2019-05-17 |
| qwo | Biologic Licensing Application | 2022-07-22 |
| xiaflex | Biologic Licensing Application | 2024-04-05 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| burns | — | D002056 | T30.0 |
| skin ulcer | HP_0200042 | D012883 | L98.4 |
Agency Specific
FDA
EMA
Expiration | Code | ||
|---|---|---|---|
collagenase clostridium histolyticum, Xiaflex, Auxilium Pharmaceuticals, Inc. | |||
| 2120-12-06 | Orphan excl. | ||
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
135 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dupuytren contracture | D004387 | EFO_0004229 | M72.0 | 1 | 2 | 13 | 9 | 12 | 37 |
| Contracture | D003286 | HP_0001371 | M62.4 | 1 | 2 | 8 | 8 | 9 | 28 |
| Penile induration | D010411 | — | N48.6 | — | 2 | 5 | 5 | 5 | 17 |
| Ulcer | D014456 | MPATH_579 | — | 2 | 2 | 2 | 8 | 3 | 16 |
| Cellulite | D000071697 | — | — | 1 | 7 | 3 | 2 | 1 | 14 |
| Diabetic foot | D017719 | EFO_1001459 | — | 1 | — | — | 8 | 1 | 10 |
| Foot ulcer | D016523 | — | — | 1 | — | — | 8 | — | 9 |
| Burns | D002056 | — | T30.0 | — | 1 | — | 2 | 2 | 5 |
| Pressure ulcer | D003668 | — | — | — | — | 1 | 2 | 1 | 4 |
| Wounds and injuries | D014947 | — | T14.8 | — | — | — | 1 | 3 | 4 |
Show 6 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Edema | D004487 | HP_0000969 | R60.9 | 2 | 5 | 3 | — | 1 | 11 |
| Macular edema | D008269 | — | — | — | — | 1 | — | — | 1 |
| Retinal diseases | D012164 | HP_0000479 | H35.9 | — | — | 1 | — | — | 1 |
| Diabetic retinopathy | D003930 | EFO_0003770 | — | — | — | 1 | — | — | 1 |
| Skin ulcer | D012883 | HP_0200042 | L98.4 | — | 1 | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Bursitis | D002062 | EFO_1000941 | M71.9 | — | 4 | — | — | — | 4 |
| Keloid | D007627 | EFO_0004212 | L91.0 | — | 2 | — | — | — | 2 |
| Cutis laxa | D003483 | — | Q82.8 | — | 1 | — | — | 1 | 2 |
| Varicose ulcer | D014647 | — | — | — | 1 | — | — | 1 | 2 |
| Lipoma | D008067 | — | D17.9 | — | 2 | — | — | — | 2 |
| Abdominal aortic aneurysm | D017544 | EFO_0004214 | — | — | 1 | — | — | — | 1 |
| Aneurysm | D000783 | HP_0002617 | I72.9 | — | 1 | — | — | — | 1 |
| Aortic aneurysm | D001014 | EFO_0001666 | I71.9 | — | 1 | — | — | — | 1 |
| Non-small-cell lung carcinoma | D002289 | — | — | 1 | 1 | — | — | — | 1 |
| Lung neoplasms | D008175 | HP_0100526 | C34.90 | 1 | 1 | — | — | — | 1 |
Show 11 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Infections | D007239 | EFO_0000544 | — | 1 | — | — | — | — | 1 |
| Coronavirus infections | D018352 | EFO_0007224 | B34.2 | 1 | — | — | — | — | 1 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 1 | — | — | — | — | 1 |
| Lung diseases | D008171 | HP_0002088 | J98.4 | 1 | — | — | — | — | 1 |
| Viral pneumonia | D011024 | EFO_0007541 | J12.9 | 1 | — | — | — | — | 1 |
| Communicable diseases | D003141 | — | — | 1 | — | — | — | — | 1 |
| Idiopathic pulmonary fibrosis | D054990 | — | J84.112 | 1 | — | — | — | — | 1 |
| Pulmonary fibrosis | D011658 | — | — | 1 | — | — | — | — | 1 |
| Interstitial lung diseases | D017563 | HP_0006530 | J84.89 | 1 | — | — | — | — | 1 |
| Pulmonary alveolar proteinosis | D011649 | HP_0006517 | J84.01 | 1 | — | — | — | — | 1 |
Show 15 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Erectile dysfunction | D007172 | EFO_0004234 | F52.21 | — | — | — | — | 2 | 2 |
| Heart failure | D006333 | HP_0001635 | I50 | — | — | — | — | 1 | 1 |
| Spontaneous abortion | D000022 | EFO_1001255 | O00.1 | — | — | — | — | 1 | 1 |
| Wound healing | D014945 | GO_0042060 | — | — | — | — | — | 1 | 1 |
| Vitiligo | D014820 | EFO_0004208 | L80 | — | — | — | — | 1 | 1 |
| Facial injuries | D005151 | — | S09.93 | — | — | — | — | 1 | 1 |
| Necrosis | D009336 | — | — | — | — | — | — | 1 | 1 |
| Hereditary corneal dystrophies | D003317 | HP_0007802 | H18.5 | — | — | — | — | 1 | 1 |
| Hernia | D006547 | HP_0100790 | K40-K46 | — | — | — | — | 1 | 1 |
| Intervertebral disc displacement | D007405 | EFO_1001800 | — | — | — | — | — | 1 | 1 |
Show 6 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Collagenase clostridium histolyticum |
| INN | — |
| Description | Collagenase clostridium histolyticum is an enzyme produced by the bacterium Clostridium histolyticum that dismantles collagen. It is used as a powder-and-solvent injection kit for the treatment of Dupuytren's contracture, a condition where the fingers bend towards the palm and cannot be fully straightened, and Peyronie's disease, a connective tissue disorder involving the growth of fibrous plaques in the soft tissue of the penis. BioSpecifics Technologies developed the preparation, which is manufactured and marketed by Endo Pharmaceuticals as Xiaflex in the US and by Sobi as Xiapex in Europe.
|
| Classification | Enzyme |
| Drug class | enzymes; quaternary ammonium derivatives |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | 9001-12-1 |
| RxCUI | 898492 |
| ChEMBL ID | CHEMBL2108709 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | DB00048 |
| UNII ID | — |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Xiaflex – Auxilium Pharmaceuticals
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Estimated US medical usage
Collagenase clostridium histolyticum
+
Collagenase
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 63,177 documents
View more details
Safety
Black-box Warning
Black-box warning for: Xiaflex
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
6,797 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use